Facebook Instagram Pinterest Reddit Tumblr X Youtube
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
PsyNews.com
  • Home
  • About
  • News
  • Events
  • Shop
  • Directory
  • Contact Us
Home Featured Page 203

Featured

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Q1 2026 Psychedelic Patent Update

The Psychedelic Practitioner Issue 4: Integration

Shane Mauss – Comedy and Molecules – Episode 14

March 2026 Psychedelic Bill Round-up

Ketamine-Assisted Couple Therapy Training by Enamory

Stephen Hurst Resigns from MindMed Board of Directors

Mydecine Innovations Group Engages JBN Partners, LLC for Marketing Services

Psychedelic Bulletin: Big Pharma’s Foray Into Psychedelics; Psilocybin Trial Makes Headlines;...

Cybin Announces Additional Adelia Milestone Achievement

PT282 – Rabbi Zac Kamenetz & The Rev. Hunt Priest –...

Levitee Labs Announces Medical Advisory Board

Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second...

Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory...

Field Trip Announces Intention to Make Applications on Behalf of Patients...

PharmaTher Announces Publication of Research Data for KETABET™

Load more

EDITOR PICKS

Q1 2026 Psychedelic Patent Update

The Psychedelic Practitioner Issue 4: Integration

Shane Mauss – Comedy and Molecules – Episode 14

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

    ABOUT US
    PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.
    FOLLOW US
    Facebook Instagram Pinterest Reddit Tumblr X Youtube
    ©